Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed director

Lexaria Bioscience Corp. (LEXX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 8-K Quarterly results
10/04/2023 D Form D - Notice of Exempt Offering of Securities:
10/03/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "PLACEMENT AGENCY",
"PRE-FUNDED COMMON",
"PRIVATE PLACEMENT WARRANT",
"OPINION OF SICHENZIA",
"SECURITIES PURCHASE"
10/02/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/23/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/09/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
07/28/2023 8-K Quarterly results
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2023 8-K Quarterly results
07/14/2023 10-Q Quarterly Report for the period ended May 31, 2023
06/12/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/12/2023 8-K Entry into a Material Definitive Agreement  Interactive Data
05/10/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Placement Agency Agreement",
"Lexaria Bioscience Announces Pricing of $2.0 Million Public Offering"
05/10/2023 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
05/10/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/09/2023 EFFECT Form EFFECT - Notice of Effectiveness:
04/28/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
04/14/2023 10-Q Quarterly Report for the period ended February 28, 2023
04/03/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
03/22/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/10/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
03/03/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "INVESTOR CONTACT:"
02/27/2023 4 TURKEL CATHERINE C. (Director) has filed a Form 4 on Lexaria Bioscience Corp.
Txns: Bought 1,500 shares @ $2.8446, valued at $4.3k
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/23/2023 8-K Regulation FD Disclosure  Interactive Data
01/18/2023 10-Q/A Quarterly Report for the period ended November 30, 2022 [amend]
01/17/2023 10-Q Quarterly Report for the period ended November 30, 2022
01/17/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Letter from the CEO"
12/30/2022 EFFECT Form EFFECT - Notice of Effectiveness:
12/21/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/06/2022 10-K/A Annual Report for the period ended August 31, 2022 [amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy